
Sailong Pharmaceutical Group Co., Ltd. — Investor Relations & Filings
Sailong Pharmaceutical Group Co., Ltd. is a pharmaceutical enterprise focused on the research, development, production, and marketing of high-end generic drugs and innovative formulations. The company maintains an integrated industrial chain encompassing active pharmaceutical ingredients (APIs) and finished dosage forms. Its product portfolio primarily targets therapeutic areas such as cardiovascular and cerebrovascular diseases, the digestive system, and anti-infective treatments. Key products include Monosialotetrahexosylganglioside Sodium Injection and Pantoprazole Sodium for Injection. The group emphasizes technological innovation and quality control to provide clinical solutions for complex medical conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于选举董事长及董事会专门委员会委员的公告 | 2025-08-27 | Chinese | |
| 关于公司聘任荣誉董事长的公告 | 2025-08-27 | Chinese | |
| 第四届董事会第十二次会议决议公告 | 2025-08-27 | Chinese | |
| 关于赛隆药业集团股份有限公司2025年第一次临时股东大会的法律意见书 | 2025-08-26 | Chinese | |
| 关于董事补选完成的公告 | 2025-08-26 | Chinese | |
| 2025年第一次临时股东大会决议公告 | 2025-08-26 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 38450134 | 关于选举董事长及董事会专门委员会委员的公告 | 2025-08-27 | Chinese | ||
| 38450114 | 关于公司聘任荣誉董事长的公告 | 2025-08-27 | Chinese | ||
| 38450096 | 第四届董事会第十二次会议决议公告 | 2025-08-27 | Chinese | ||
| 38450084 | 关于赛隆药业集团股份有限公司2025年第一次临时股东大会的法律意见书 | 2025-08-26 | Chinese | ||
| 38450061 | 关于董事补选完成的公告 | 2025-08-26 | Chinese | ||
| 38450042 | 2025年第一次临时股东大会决议公告 | 2025-08-26 | Chinese | ||
| 38450029 | 关于子公司停产检修的进展公告 | 2025-08-25 | Chinese | ||
| 38450014 | 第四届董事会第十一次会议决议公告 | 2025-08-20 | Chinese | ||
| 38450010 | 关于2025年第一次临时股东大会取消部分议案暨补充通知的公告 | 2025-08-20 | Chinese | ||
| 38449994 | 关于子公司停产检修的公告 | 2025-08-11 | Chinese | ||
| 38449981 | 关于参加最近一次独立董事培训的承诺书(张建民) | 2025-08-10 | Chinese | ||
| 38449968 | 独立董事提名人声明与承诺(张建民) | 2025-08-10 | Chinese | ||
| 38449959 | 第四届董事会提名委员会2025年第一次会议审查意见 | 2025-08-10 | Chinese | ||
| 38449939 | 公司章程修正案(2025年8月) | 2025-08-10 | Chinese | ||
| 38449904 | 关于补选公司第四届董事会董事的公告 | 2025-08-10 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Sailong Pharmaceutical Group Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/54895/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=54895 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=54895 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=54895 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 54895}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Sailong Pharmaceutical Group Co., Ltd. (id: 54895)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.